The peak of the AI frenzy has passed
When did the AI frenzy peak and what does it mean for tech companies?

A new month, a new market wobble. Global stocks began September with their worst sell-off since the early August shocker. America’s technology-focused Nasdaq Composite index dropped by 3.3% on 3 September, with artificial intelligence (AI) flagship Nvidia suffering a 9.5% slide. The resulting $279 billion fall in value marks the biggest one-day decline in the market cap of a US stock in history.
While last month’s plunge began in Japan, this time concern is focused squarely on America. Weak manufacturing data revived fears that the US is on the brink of recession. Nervous markets have become prone to exaggerate “the likely scale of the impending US economic slowdown”, triggering overreactions to small bits of bad data, says Katie Martin in the Financial Times.
While overvalued “monster” tech stocks flail, the rest of the world’s top economy isn’t looking too bad. Société Générale analysts note that 80% of US stocks beat earnings-per-share expectations in the most recent quarter. Investors should shift their attention from the narrow AI “bubble” to opportunities across the rest of the market, especially in “small- and mid-cap stocks”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
How are AI companies performing?
The Nvidia sell-off came even though the company delivered another set of “blowout results” last week, says Ipek Ozkardeskaya of Swissquote Bank. The AI-chip specialist topped sales forecasts by $2 billion for the fifth consecutive quarter, served up an unexpectedly robust forecast for the current quarter and announced a big stock buyback. It still wasn’t enough. The shares fell 14% over the next three days.
Investor “fatigue” with the AI story is evident. Nvidia’s shares have dropped a fifth since a mid-June peak, but have still risen more than 600% since the beginning of last year. “Nvidia is doing fine,” says Dan Gallagher in The Wall Street Journal. The other tech giants lavished $58.5 billion on AI capital spending in the second quarter – great news for Nvidia, which captures a lot of that money by selling its high-end chips to these firms for their AI projects. Projected revenue for the current quarter came in 2% ahead of Wall Street targets, but investors have become used to even bigger beats – in the same quarter last year, revenue outperformed expectations by 28%.
There are question marks about whether this earnings windfall will be sustainable if consumer demand for AI services fails to appear and tech firms rein in AI spending, but there is little reason to panic yet. Nvidia enjoys huge profit margins of more than 50%, five times the average for the S&P 500 as a whole, says John Authers on Bloomberg. Investors were disappointed by signs that rising margins won’t continue forever. Talk about a reality check.
The Nvidia share price is unlikely “to burst”, but “speculative froth” is being removed. Peter Atwater of Financial Insyghts notes that prices of the most “speculative” AI trades actually peaked in the spring and have since dropped a fifth. As Atwater puts it, the “peak in the AI frenzy is behind us. Unappreciated by the crowd, it occurred in late February. As they always do, the worst left the party first”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Read more
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
How much should I have in emergency savings?
When your boiler breaks or your car won’t start, you can find yourself paying a hefty bill. How much should you have in emergency savings to cover unexpected costs?
By Katie Williams Published
-
ISA investments by age: should I invest more in my stocks and shares ISA?
Stocks and shares ISAs are a great way to grow long-term wealth, but are they overlooked compared to cash savings? We look at the average ISA investment by age and if you should have more.
By Dan McEvoy Published
-
Is the AI boom another dotcom bubble?
25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
By Dan McEvoy Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published